<div class="table-responsive">
    <table class="table table-striped table-hover">
        <thead>
            <tr>
                
                <th scope="col">
                    <a href="?cresstrial=10491&amp;modal=1&amp;valnames=arms&amp;order=created_at">Created at</a>
                </th>
                <th scope="col">Source</th>
                
                <th scope="col">Raw Value</th>
                <th scope="col">Validated value</th>
            </tr>
        </thead>
        <tbody>
            
            <tr class="histvalue-row" histvalueid="418497" class="table-">
                
                <td>July 7, 2022, 1:30 p.m.</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Drug;D02.540.576.500.992.050;D03.633.100.810.050.180.350;1. Control group - 210 participantsControl group will recieve proper COVID19 treatment but will not recieve hydroxychloroquine; chloroquine; azythromicyn or other macrolide.2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 1534, &quot;treatment_name&quot;: &quot;Azithromycin+hydroxychloroquine&quot;, &quot;treatment_type&quot;: &quot;Antibiotics+antimalarials&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 607, &quot;treatment_name&quot;: &quot;Hydroxychloroquine&quot;, &quot;treatment_type&quot;: &quot;Antimalarials&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 2188, &quot;treatment_name&quot;: &quot;Standard of care&quot;, &quot;treatment_type&quot;: &quot;Standard of care&quot;, &quot;pharmacological_treatment&quot;: &quot;Standard of care&quot;}]
        </p>
        
    
                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="415202" class="table-">
                
                <td>June 23, 2022, 2 p.m.</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;1. Control group - 210 participantsControl group will recieve proper COVID19 treatment but will not recieve hydroxychloroquine; chloroquine; azythromicyn or other macrolide.2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days;Drug;D03.633.100.810.050.180.350;D02.540.576.500.992.050&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days;Drug;D03.633.100.810.050.180.350;D02.540.576.500.992.050&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 2188, &quot;treatment_name&quot;: &quot;Standard of care&quot;, &quot;treatment_type&quot;: &quot;Standard of care&quot;, &quot;pharmacological_treatment&quot;: &quot;Standard of care&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 1534, &quot;treatment_name&quot;: &quot;Azithromycin+hydroxychloroquine&quot;, &quot;treatment_type&quot;: &quot;Antibiotics+antimalarials&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 607, &quot;treatment_name&quot;: &quot;Hydroxychloroquine&quot;, &quot;treatment_type&quot;: &quot;Antimalarials&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}]
        </p>
        
    
                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="414291" class="table-">
                
                <td>June 17, 2022, 12:30 p.m.</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;D02.540.576.500.992.050;D03.633.100.810.050.180.350;Drug;1. Control group - 210 participantsControl group will recieve proper COVID19 treatment but will not recieve hydroxychloroquine; chloroquine; azythromicyn or other macrolide.2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 1534, &quot;treatment_name&quot;: &quot;Azithromycin+hydroxychloroquine&quot;, &quot;treatment_type&quot;: &quot;Antibiotics+antimalarials&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 607, &quot;treatment_name&quot;: &quot;Hydroxychloroquine&quot;, &quot;treatment_type&quot;: &quot;Antimalarials&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 2188, &quot;treatment_name&quot;: &quot;Standard of care&quot;, &quot;treatment_type&quot;: &quot;Standard of care&quot;, &quot;pharmacological_treatment&quot;: &quot;Standard of care&quot;}]
        </p>
        
    
                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="390930" class="table-">
                
                <td>March 29, 2022, 12:06 p.m.</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;1. Control group - 210 participantsControl group will recieve proper COVID19 treatment but will not recieve hydroxychloroquine; chloroquine; azythromicyn or other macrolide.2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days;Drug;D03.633.100.810.050.180.350;D02.540.576.500.992.050&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days;Drug;D03.633.100.810.050.180.350;D02.540.576.500.992.050&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 1534, &quot;treatment_name&quot;: &quot;Azithromycin+hydroxychloroquine&quot;, &quot;treatment_type&quot;: &quot;Antibiotics+antimalarials&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 607, &quot;treatment_name&quot;: &quot;Hydroxychloroquine&quot;, &quot;treatment_type&quot;: &quot;Antimalarials&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 2188, &quot;treatment_name&quot;: &quot;Standard of care&quot;, &quot;treatment_type&quot;: &quot;Standard of care&quot;, &quot;pharmacological_treatment&quot;: &quot;Standard of care&quot;}]
        </p>
        
    
                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="294848" class="table-">
                
                <td>Feb. 25, 2022, noon</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;D03.633.100.810.050.180.350;D02.540.576.500.992.050;Drug;1. Control group - 210 participantsControl group will recieve proper COVID19 treatment but will not recieve hydroxychloroquine; chloroquine; azythromicyn or other macrolide.2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 607, &quot;treatment_name&quot;: &quot;Hydroxychloroquine&quot;, &quot;treatment_type&quot;: &quot;Antimalarials&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 1534, &quot;treatment_name&quot;: &quot;Azithromycin+hydroxychloroquine&quot;, &quot;treatment_type&quot;: &quot;Antibiotics+antimalarials&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 2188, &quot;treatment_name&quot;: &quot;Standard of care&quot;, &quot;treatment_type&quot;: &quot;Standard of care&quot;, &quot;pharmacological_treatment&quot;: &quot;Standard of care&quot;}]
        </p>
        
    
                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="233191" class="table-">
                
                <td>Dec. 15, 2020, 2:47 p.m.</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;1. Control group - 210 participantsControl group will recieve proper COVID19 treatment but will not recieve hydroxychloroquine; chloroquine; azythromicyn or other macrolide.2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days;Drug;D03.633.100.810.050.180.350;D02.540.576.500.992.050&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days;Drug;D03.633.100.810.050.180.350;D02.540.576.500.992.050&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="223547" class="table-">
                
                <td>Oct. 26, 2020, 8:29 a.m.</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;1. Control group - 210 participantsControl group will recieve proper COVID19 treatment but will not recieve hydroxychloroquine; chloroquine; azythromicyn or other macrolide.2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days;Drug;Hydroxychloroquine;Azithromycin&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;1. Control group - 210 participantsControl group will recieve proper COVID19 treatment but will not recieve hydroxychloroquine; chloroquine; azythromicyn or other macrolide.&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days;Drug;Hydroxychloroquine;Azithromycin&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

                </td>
            </tr>
            
        </tbody>
    </table>
</div>
Created at	Source	Raw Value	Validated value
July 7, 2022, 1:30 p.m.	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "Drug;D02.540.576.500.992.050;D03.633.100.810.050.180.350;1. Control group - 210 participantsControl group will recieve proper COVID19 treatment but will not recieve hydroxychloroquine; chloroquine; azythromicyn or other macrolide.2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]	[{"arm_notes": "", "treatment_id": 1534, "treatment_name": "Azithromycin+hydroxychloroquine", "treatment_type": "Antibiotics+antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 607, "treatment_name": "Hydroxychloroquine", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
June 23, 2022, 2 p.m.	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "1. Control group - 210 participantsControl group will recieve proper COVID19 treatment but will not recieve hydroxychloroquine; chloroquine; azythromicyn or other macrolide.2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days;Drug;D03.633.100.810.050.180.350;D02.540.576.500.992.050", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days;Drug;D03.633.100.810.050.180.350;D02.540.576.500.992.050", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]	[{"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}, {"arm_notes": "", "treatment_id": 1534, "treatment_name": "Azithromycin+hydroxychloroquine", "treatment_type": "Antibiotics+antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 607, "treatment_name": "Hydroxychloroquine", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}]
June 17, 2022, 12:30 p.m.	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "D02.540.576.500.992.050;D03.633.100.810.050.180.350;Drug;1. Control group - 210 participantsControl group will recieve proper COVID19 treatment but will not recieve hydroxychloroquine; chloroquine; azythromicyn or other macrolide.2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]	[{"arm_notes": "", "treatment_id": 1534, "treatment_name": "Azithromycin+hydroxychloroquine", "treatment_type": "Antibiotics+antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 607, "treatment_name": "Hydroxychloroquine", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
March 29, 2022, 12:06 p.m.	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "1. Control group - 210 participantsControl group will recieve proper COVID19 treatment but will not recieve hydroxychloroquine; chloroquine; azythromicyn or other macrolide.2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days;Drug;D03.633.100.810.050.180.350;D02.540.576.500.992.050", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days;Drug;D03.633.100.810.050.180.350;D02.540.576.500.992.050", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]	[{"arm_notes": "", "treatment_id": 1534, "treatment_name": "Azithromycin+hydroxychloroquine", "treatment_type": "Antibiotics+antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 607, "treatment_name": "Hydroxychloroquine", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
Feb. 25, 2022, noon	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "D03.633.100.810.050.180.350;D02.540.576.500.992.050;Drug;1. Control group - 210 participantsControl group will recieve proper COVID19 treatment but will not recieve hydroxychloroquine; chloroquine; azythromicyn or other macrolide.2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]	[{"arm_notes": "", "treatment_id": 607, "treatment_name": "Hydroxychloroquine", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1534, "treatment_name": "Azithromycin+hydroxychloroquine", "treatment_type": "Antibiotics+antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
Dec. 15, 2020, 2:47 p.m.	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "1. Control group - 210 participantsControl group will recieve proper COVID19 treatment but will not recieve hydroxychloroquine; chloroquine; azythromicyn or other macrolide.2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days;Drug;D03.633.100.810.050.180.350;D02.540.576.500.992.050", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days;Drug;D03.633.100.810.050.180.350;D02.540.576.500.992.050", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]
Oct. 26, 2020, 8:29 a.m.	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "1. Control group - 210 participantsControl group will recieve proper COVID19 treatment but will not recieve hydroxychloroquine; chloroquine; azythromicyn or other macrolide.2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days;Drug;Hydroxychloroquine;Azithromycin", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "1. Control group - 210 participantsControl group will recieve proper COVID19 treatment but will not recieve hydroxychloroquine; chloroquine; azythromicyn or other macrolide.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "2. HCQA - 210 participantsHCQA group will recieve proper COVID19 treatment and hydroxychloroquine 400mg + azythromicyn 500mg once a day; oral; enteral or intravenous; for 7 days", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "3. HCQ - 210 participantsHCQ group will recieve proper COVID19 treatment; and hydroxychloroquine 400mg once a day; oral; enteral or intravenous; for 7 days;Drug;Hydroxychloroquine;Azithromycin", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]